Diabetes drug Ozempic Shortage in UK: Touted as weight-loss drug
- Early Biomarker for Multiple Sclerosis Development Identified Years in Advance
- Aspirin Found Ineffective in Improving Recurrence Risk or Survival Rate of Breast Cancer Patients
- Child Products from Aliexpess and Temu Contain Carcinogens 3026x Over Limit
- Daiichi Sankyo/AstraZeneca’s Enhertu Shows Positive Results in Phase III DESTINY-Breast06 Clinical Trial
- Mn007 Molecules Offer Potential for Combating Streptococcus pyogenes Infection
- Popular Indian Spices Banned in Hong Kong Over Carcinogen Concerns
Diabetes drug Ozempic Shortage in UK: Touted as weight-loss drug
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Diabetes drug Ozempic Shortage in UK: Touted as weight-loss drug
Pharmacies in UK are facing a “severe shortage” of type 2 diabetes drug Ozempic (Semaglutide) as it is increasingly promoted as a weight-loss wonder drug by celebrities including the Kardashians and Elon Musk, putting at risk diabetics who really need it to save their lives.
The UK Department of Health and Social Care has confirmed that the country is experiencing a shortage of Ozempic that will not be resolved “until at least mid-2024”.
A pharmacist named Ali Abass expressed his concerns, saying: “Most patients have no other options. A lot of people won’t use anything else.”
Some people with diabetes said they were “very concerned” because Ozempic was the only drug that worked for them. One patient, Marie Indge, said she only had about two months of medication left and was concerned about finding an alternative to manage her condition.
The UK’s medicines watchdog urged diabetics to “must preserve existing stocks”.
Information about Ozempic:
Ozempic, whose generic name is semaglutide, is a prescription medication used to treat type 2 diabetes mellitus.
It belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists).
GLP-1 receptor agonists work by mimicking the action of the GLP-1 hormone, which helps regulate blood sugar levels in the body.
Semaglutide helps lower blood sugar levels by increasing insulin production and reducing the release of glucose from the liver.
It also slows down the emptying of the stomach, which can help with appetite control and weight management in some individuals.
Ozempic is typically administered as a once-weekly injection using a pre-filled pen.
The dosage may vary based on individual needs, and it is important to follow the prescribed dose and administration instructions provided by a healthcare professional.
It is worth noting that Ozempic is not recommended for the treatment of type 1 diabetes or diabetic ketoacidosis (a serious complication of diabetes).
It is essential to inform your doctor about any other medications you are taking and any medical conditions you have before starting Ozempic, as it may interact with certain drugs or be contraindicated in specific situations.
As with any medication, Ozempic may have side effects, and it is crucial to discuss potential risks and benefits with your doctor to determine if it is a suitable option for your diabetes management.
Always follow your healthcare provider’s recommendations and monitor your blood sugar levels regularly while taking Ozempic.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
